Reimagining Women's Health

Reimagining Women’s Health

Frost & Sullivan’s recent analysis, Reimagining Women’s Health, presented at Arab Health by our Healthcare and Life Sciences Partner and Senior Vice President, Reenita Das, focuses on the evolving healthcare issues of women, such as menopause and infertility. She urges the healthcare industry to address them by developing holistic and personalized care delivery models.

With the requirement to deliver health equity for 4.3 billion women globally, the analysis highlights Women in Transition Symptoms Management & Holistic Care as an untapped high-growth potential market. The changing landscape of women’s healthcare needs presents ten lucrative growth opportunities by 2030, including the need for:

  • Screening beyond breast cancer in emerging markets.
  • Women-specific care for cardiac and diabetes.
  • Affordable menstrual care solutions in emerging markets.
  • Advanced fertility solutions for developing markets.
  • Healthcare, wellness, cosmetics, and aesthetics industries to capture opportunities that address increasing life expectancy and demand for longevity solutions.
  • Sexual health solutions for menopausal women/cancer patients.

“To improve women’s healthcare, we need the healthcare sectors to move beyond male mice representation in pre-clinical trials and increase female representation from 20% to more,” said Reenita Das. “Additionally, despite the readiness of technology to deliver better healthcare for women, the existing policy and reimbursement systems are refraining them from taking advantage, so it is time for governments and concerned agencies to mull over such policies and change them.”

Das added: “The step toward health equity begins with correcting language or terminology we use. It is better to say ‘women in transition’ rather than menopause because it lasts for twenty to thirty years; hence, it is not a ‘pause’.”

Reimagining Women’s Health is the latest addition to Frost & Sullivan’s Healthcare analysis available through the Frost & Sullivan Leadership Council, which helps organizations identify a continuous flow of growth opportunities to succeed in an unpredictable future.

About Reenita Das

Reenita Das currently serves as Healthcare and Life Sciences’ Partner and Senior Vice President and is the first woman Partner at Frost & Sullivan, driving the global research vision and strategy for the firm and commercial opportunities within the healthcare practice. She has lived and worked in over ten countries, focusing on finding solutions to healthcare challenges and implementing growth change strategies. She recently got voted the top 100 women in Femtech and Healthtech. Reenita’s focus is on how healthcare will operate 20 years from today, and she shares her vision at leading conferences and events.

Reenita Das

Reenita Das currently serves as Healthcare and Life Sciences’ Partner and Senior Vice President and is the first woman Partner at Frost & Sullivan, driving the global research vision and strategy for the firm and commercial opportunities within the healthcare practice. She has lived and worked in over ten countries, focusing on finding solutions to healthcare challenges and implementing growth change strategies. She recently got voted the top 100 women in Femtech and Healthtech. Reenita’s focus is on how healthcare will operate 20 years from today, and she shares her vision at leading conferences and events.

Your Transformational Growth Journey Starts Here